NeonMind Biosciences Inc.: NeonMind Appoints Emergency and A

VANCOUVER, BC / ACCESSWIRE / February 23, 2022 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind' or the "Company"), an integrated drug development and wellness company focused on

Related Keywords

Canada , Toronto , Ontario , Vancouver , British Columbia , Canadian , Rob Tessarolo , Dinesh Bhayana , Scott Eckstein Tim Regan , Robert Tessarolo , Mcmaster University , Integrative Psychiatry Institute , Polaris Insight Center , Schulich School Of Medicine , University Of Toronto , Strategic Communications , Neonmind Biosciences Inc , Canadian College Of Family Physicians , Canadian Securities Exchange , Centre For Compassionate Care , Neonmind Biosciences , Site Medical Director , Chief Medical Officer , Compassionate Care , Board Member , Multidisciplinary Association , Psychedelic Studies , Addiction Medicine , Greater Toronto , Specialty Clinics Advisory Board , Emergency Medicine , Schulich School , Canadian College , Family Physicians , Assistant Clinical Professor , Ketamine Medical Provider , Chief Executive Officer , Neonmind , Iosciences , Ppoints , Emergency , Addiction , Expert , Dinesh , Bhayana , Bite , Medical , Director , Inaugural , Specialty , Ental , Health , Clinic ,